Cardiac performance after reduction of myocardial hypertrophy
- PMID: 2525877
- DOI: 10.1016/s0002-9343(89)80478-4
Cardiac performance after reduction of myocardial hypertrophy
Abstract
Purpose: The current study was performed to assess the functional sequelae of reducing left ventricular hypertrophy in patients with essential hypertension.
Patients and methods: To analyze left ventricular function and contractility in patients with essential hypertension after reduction of left ventricular hypertrophy, 14 patients with essential hypertension and left ventricular hypertrophy were studied prospectively by echocardiogram (1) before, (2) during, and (3) after left ventricular mass had been reduced by antihypertensive therapy of 19 +/- 3 months' duration. All drugs were discontinued four weeks before the first and the third study.
Results: At the time of the third study, arterial pressure had returned to pretreatment values, and mean, peak, and isovolumetric (but not end-systolic) wall stress increased, whereas left ventricular mass remained diminished. Despite the increased pressure load to the heart, myocardial contractility was maintained or improved after reduction of left ventricular hypertrophy, as indicated by the ratio of end-systolic wall stress to end-systolic volume index (p less than 0.02) and by the relation of fractional shortening to end-systolic wall stress (p less than 0.06). End-diastolic volume, an indicator of preload, remained reduced after therapy (p less than 0.05). As a result, pump function of the left ventricle improved as shown by an increase in the ejection fraction (p less than 0.05), fractional fiber shortening (p less than 0.05), and velocity of circumferential fiber shortening (p less than 0.01).
Conclusion: Thus, in patients with essential hypertension, reduction of myocardial hypertrophy by antihypertensive therapy appears to be beneficial rather than detrimental to cardiac pump performance.
Similar articles
-
Cardiac determinants of regression of left ventricular hypertrophy in essential hypertension with antihypertensive treatment.J Am Coll Cardiol. 1990 Mar 1;15(3):665-71. doi: 10.1016/0735-1097(90)90643-4. J Am Coll Cardiol. 1990. PMID: 2137479
-
Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension.Am J Cardiol. 1983 Jan 1;51(1):171-6. doi: 10.1016/s0002-9149(83)80031-9. Am J Cardiol. 1983. PMID: 6217738
-
Supernormal contractility in primary hypertension without left ventricular hypertrophy.Hypertension. 1988 May;11(5):457-63. doi: 10.1161/01.hyp.11.5.457. Hypertension. 1988. PMID: 2966769
-
Risk reduction following regression of cardiac hypertrophy.Clin Exp Hypertens A. 1990;12(5):903-16. doi: 10.3109/10641969009073508. Clin Exp Hypertens A. 1990. PMID: 2145097 Review.
-
Systolic and diastolic function following regression of left ventricular hypertrophy in hypertension.J Hypertens Suppl. 1991 Dec;9(2):S51-5. doi: 10.1097/00004872-199112002-00007. J Hypertens Suppl. 1991. PMID: 1838768 Review.
Cited by
-
Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy.Curr Hypertens Rep. 2000 Jun;2(3):260-70. doi: 10.1007/s11906-000-0009-z. Curr Hypertens Rep. 2000. PMID: 10981159 Review.
-
Left ventricular hypertrophy is independently associated with all-cause mortality.Am J Cardiovasc Dis. 2022 Feb 15;12(1):38-41. eCollection 2022. Am J Cardiovasc Dis. 2022. PMID: 35291507 Free PMC article.
-
Left Ventricular Hypertrophy.Curr Treat Options Cardiovasc Med. 1999 Oct;1(3):219-230. doi: 10.1007/s11936-999-0038-0. Curr Treat Options Cardiovasc Med. 1999. PMID: 11096487
-
Regression of increased left ventricular mass by antihypertensives.Drugs. 1991 Dec;42(6):945-61. doi: 10.2165/00003495-199142060-00004. Drugs. 1991. PMID: 1724641 Review.
-
Risk and management of hypertension-related left ventricular hypertrophy.Drugs. 1995 Dec;50(6):959-70. doi: 10.2165/00003495-199550060-00004. Drugs. 1995. PMID: 8612474 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials